Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL

The Janus kinase 3 (JAK3) tyrosine kinase is mutated in 10% to 16% of T-cell acute lymphoblastic leukemia (T-ALL) cases. JAK3 mutants induce constitutive JAK/STAT signaling and cause leukemia when expressed in the bone marrow cells of mice. Surprisingly, we observed that one third of JAK3-mutant T-A...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Degryse, Sandrine, Bornschein, Simon, de Bock, Charles E., Leroy, Emilie, Vanden Bempt, Marlies, Demeyer, Sofie, Jacobs, Kris, Geerdens, Ellen, Gielen, Olga, Soulier, Jean, Harrison, Christine J., Constantinescu, Stefan N., Cools, Jan
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2018
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5796683/
https://ncbi.nlm.nih.gov/pubmed/29187379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-07-797597
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars